Latest News
- Grant awarded to develop new imaging techniques that target tumor environment
Dr. Jeremie Calais has been awarded $105,000 from the Society of Nuclear Medicine and Molecular Imaging. The two-year grant will help fund a new UCLA-led study that aims to advance the method of locating cancer by detecting tumor stroma.
November 18, 2019 10:00 AM
detail - New screening method identifies inhibitors of cancer cell metabolism
A new screening system leverages redundancy in an important component of a cell to help identify new drugs that specifically and potently block processes that are essential for cancer cell growth.
November 18, 2019 8:00 AM
detail - Three UCLA scientists receive grants totaling more than $18 million
Three UCLA researchers have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state’s stem cell agency.
November 01, 2019 8:00 AM
detail - National Cancer Institute awards UCLA prostate cancer program an $8.7 million grant
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.
October 31, 2019 10:00 AM
detail - Mitochondria’s activity in tumors could predict response to lung cancer drug
Researchers at the UCLA Jonsson Comprehensive Cancer Center and David Geffen School of Medicine at UCLA have identified a new biomarker that could indicate how likely someone is to respond to treatment for lung cancer.
October 30, 2019 11:00 AM
detail - Lung cancer patients with depression likely to receive radiotherapy over surgery
Researchers from the UCLA Jonsson Comprehensive Cancer Center and the Dana-Farber Cancer Institute analyzed 515 patients with early stage non-small-cell lung cancer who were age 65 and older.
October 29, 2019 2:30 PM
detail - Two early career researchers honored by Prostate Cancer Foundation
The Prostate Cancer Foundation has honored two UCLA researchers, Dr. Amar Kishan and Dr. Jeremy Shelton, with PCF Young Investigator awards as part of their 2019 class.
October 29, 2019 8:00 AM
detail - Two UCLA doctors named to National Academy of Medicine
Two UCLA professors, Dr. Denise Aberle and Dr. Carol Mangione, have been elected to the National Academy of Medicine, one of the highest honors in health and medicine.
October 21, 2019 9:00 AM
detail - Creatine powers T cells’ fight against cancer
Creatine, the organic acid that is popularly taken as a supplement by athletes and bodybuilders, serves as a molecular battery for immune cells by storing and distributing energy to power their fight against cancer, according to new UCLA research.
October 18, 2019 9:00 AM
detail - UCLA opens pioneering CAR T clinical trial aimed at extending the lives of people diagnosed with the most common types of lymphoma and leukemia
The field of immunotherapy has revolutionized the way people with incurable cancers are treated, saving the lives of many people whose disease would have otherwise been seen as a death sentence.
October 16, 2019 8:00 AM
detail - Antibody eradicates leukemia stem cells
UCLA researchers have discovered a way to eliminate the CML stem cells. Their approach uses an antibody to block a protein that the stem cells rely on to grow.
October 15, 2019 10:00 AM
detail - Cancer researcher honored for work advancing immunotherapy
The Cancer Research Institute has awarded Dr. Antoni Ribas, director of the tumor immunology program at the UCLA Jonsson Comprehensive Cancer Center, with the 2019 William B. Coley Award for his distinguished research in basic and tumor immunology.
October 14, 2019 8:00 AM
detail - Expert second opinion improves reliability of melanoma diagnoses
UCLA researchers have found that obtaining a second opinion from pathologists who are board certified or have fellowship training in dermatopathology can help improve the accuracy and reliability of diagnosing melanoma, one of the deadliest and most aggressive forms of skin cancer.
October 11, 2019 8:00 AM
detail - Clues from DNA could help predict growth of prostate cancer
Researchers from the UCLA Jonsson Comprehensive Cancer Center and other institutions in the U.S., Canada, the United Kingdom and Singapore, have identified 1,178 biomarkers in men’s genome that predict how an individual person’s prostate cancer will grow.
October 07, 2019 9:00 AM
detail - Cancer Support Community Los Angeles honors UCLA psychologist
Annette Stanton, professor of psychology in the UCLA College, will receive the Harold H. Benjamin Innovation Award from the Cancer Support Community Los Angeles at the organization’s fifth annual Gilda Gala in October.
October 03, 2019 8:00 AM
detail - UCLA physician scientists awarded $500,000 for pediatric cancer research
Two UCLA doctors have received grants totaling $500,000 to fund research into treatments for pediatric cancer from Hyundai Hope On Wheels.
October 02, 2019 8:00 AM
detail - NIH grant awarded to physician-scientist to develop novel ways to manufacture cellular therapies
The National Institutes of Health has awarded Dr. Steven Jonas with a five-year $1.25 million grant through its High-Risk, High-Reward Research Program.
October 01, 2019 10:00 AM
detail - New hydrogels show promise in treating bone defects
Bioengineers and dentists from the UCLA School of Dentistry have developed a new hydrogel that is more porous and effective in promoting tissue repair and regeneration compared to hydrogels that are currently available.
October 01, 2019 8:00 AM
detail - MRI-guided biopsy best for determining future risk of prostate cancer, study shows
UCLA physicians have shown that the best way to proceed with this is by starting out with an MRI-guided prostate biopsy.
September 30, 2019 8:00 AM
detail - ESMO: Adding targeted therapy drug to hormone therapy helps women with aggressive breast cancer live longer
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.
September 29, 2019 7:30 AM
detail